
CAR T-Cell Therapy for Autoimmune Disease Explained | Dr. Vaneet Sandhu
What if treating your autoimmune disease didn't mean a lifetime of infusions, but one? In this episode of Autoimmune Alchemy, I talk with Dr. Vaneet Sandhu, VP of Clinical Development at Fate Therapeutics, about CAR T-cell therapy: how it reprograms immune cells to eliminate the "bad actor" B-cells driving disease, why it started in oncology and is now being tested in lupus, scleroderma, vasculitis and more, and what the recent safety headlines actually mean for patients considering a trial. Chapter and Time Stamps: 00:00 CAR T Cells Explained 01:04 Meet The Guest 02:19 What Is CAR T Therapy 03:28 Off The Shelf Manufacturing 05:39 Dosing And Infusion Basics 06:57 How CAR T Targets B Cells 08:37 B Cell Return And Reset 09:56 Diseases And Trial Phases 11:05 Timeline And Eligibility 13:37 From Cancer To Autoimmune 15:18 Early Results And Safety 20:18 Trial Pauses And Deaths 23:35 Comparing Companies 27:01 Hard To Treat Diseases 28:26 How To Join Trials 29:41 Final Thoughts And Resources Key Takeaways 🧬 A CAR T-Cell Is Just a Soldier With New Orders 🏭 Off-the-Shelf Beats Custom-Made — Here's Why 💉 One Infusion, Not a Lifetime of Them 🎯 It's Not Killing Immunity — It's Retraining It 🔄 The B-Cells That Come Back Aren't the Bad Ones 🦠 Started in Cancer, Now Rewriting Autoimmune Treatment ⚠️ Safety Headlines Aren't the Whole Story — Context Matters 🔍 Not a Cure Yet — But a Real Shot at Remission Guest Details & Links Dr.
Publisher
Autoimmune Alchemy
Link
autoimmune-alchemy.captivate.fm
Published
September 21, 2026
Duration
31 min
Format
Podcast
Category
Lifestyle · Health & Wellness
Source
RSS feed
Host
Dr. Micah Yu and Dr. Melissa Mondala
Autoimmune Alchemy
@autoimmunealchemy
#celltherapy #autoimmunediseaseexplained #vaneetsandhu #alternativehealth #mentalhealth
